Journals in Hematology
Journals in Hematology
- ISSN: 0021-9150
Atherosclerosis
Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysi... and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Preve... of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagno... Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translation... Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.
- ISSN: 2667-0895
Atherosclerosis Plus
Previously published as Atherosclerosis Supplements .Atherosclerosis Plus is supported by the European Atherosclerosis Society.Atherosclero... Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions. Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. Finally, the journal periodically publishes special theme issues devoted to areas of current interest.
- ISSN: 1521-6926
Best Practice & Research Clinical Haematology
Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology.All chapters are commissioned and written by an international team of practicing clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders.All chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.
- ISSN: 0006-4971
Blood
Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well-organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to submit a presubmission inquiry if they are uncertain whether their work falls within the general scope of the journal.Blood has formulated more precise scopes for immunobiology and immunotherapy, vascular biology, HIV/HTLV, and clinical trial submissions. The journal is very interested in submissions as reflected in the definitions linked below.Immunobiology and Immunotherapy scopeVascular Biology scopeHIV/HTLV scopeClinical Trials scopeBlood welcomes submission of manuscripts reporting on clinical trials whether phase 1, 2, 3 or 4. Reports should include a full description of the study design, patient population, methodology and conduct, and statistical plan.Immunobiology and Immunotherapy encompass a wide spectrum of research, but Blood can accommodate only papers that have clear and important implications for hematology. Preference is given to papers focusing on human immunobiology, immunotherapy, and immune pharmacology approaches in the human setting and those with significant implications for understanding of normal or malignant hematologic processes. Papers on tumor immunology, tumor vaccines and cancer immunotherapy development may be appropriate if the target cells or antigens are relevant to hematologic malignancies, but generally Blood cannot accommodate tumor immunology papers focusing solely on non-hematologic tumor types.Papers investigating autoimmunity and utilizing non-hematologic models are not within the scope of Blood.Vascular biology papers that focus primarily on atherosclerosis are outside the scope of Blood and instead should be considered for alternative journals.Papers felt to be outside the scope of Blood will be returned to the author without full peer review.
- ISSN: 0268-960X
Blood Reviews
This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned peer reviewed articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editors welcome suggestions from potential authors. They should first write a brief outline of an intended review along with their publication record on topic and send this to Dr Drew Provan ([email protected].... or to Dr Hillard Lazarus ([email protected]). All articles are subject to peer review. Author queries can also be sent to the Blood Reviews editorial office BloodReviews@elsevie...
- ISSN: 1877-7821
Cancer Epidemiology
Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).
- ISSN: 2210-7762
Cancer Genetics
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterCancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
- ISSN: 0304-3835
Cancer Letters
An international journal providing a forum for original and pertinent contributions in cancer researchCancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.Benefit... to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.else...
- ISSN: 0261-5614
Clinical Nutrition
Official Journal of ESPEN, The European Society for Clinical Nutrition and MetabolismClinical Nutrition, the official journal of ESPEN, The European Society for Clinical Nutrition and Metabolism, is an international journal providing essential scientific information on nutritional and metabolic care and the relationship between nutrition and disease both in the setting of basic science and clinical practice. Published bi-monthly, each issue combines original articles and reviews providing an invaluable reference for any specialist concerned with these fields.Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of Parenteral and Enteral Nutrition or, more broadly, Clinical Nutrition and Metabolism.Being the journal of ESPEN with members from various interests, either focused on basic research or clinical disciplines, the journal reflects the scientific nature of this multidisciplinary background and encourages the coordination of investigation and research from these disciplines. The journal publishes guidelines, consensus statements, original articles, short communications, letters to the Editor and review papers on those factors in acute and chronic diseases, which have metabolic and nutritional implications. It also publishes scientific works related to the development of new techniques and their application in the field of clinical nutrition.
- ISSN: 1040-8428
Critical Reviews in Oncology/Hematology
Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyIm... Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapy... Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritica... Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.